In particular, the authors demonstrated that FAK inhibitor-14 (FAKI-14) significantly reduced sphere formation and CD44/CD90 expression, and decreased the mRNA expression of OCT4, NANOG, SOX2, KLF4, and C-MYC in the SK-HEP1 HCC cell line. Here, POU5F1 is linked to hepatocellular carcinoma.